People News: Roche NimbleGen and ISI

Share this content:
Roche NimbleGen named Frank Pitzer CEO. Dr. Pitzer was previously head of divisional quality and regulatory affairs at Roche Diagnostics, reporting directly to the CEO, and was also a member of the Diagnostics executive committee.

ISI, a life sciences software company, named Lisa Jenkins, PhD director of regulatory strategy, responsible for advising clients on clinical development and global strategic regulatory affairs. Jenkins was previously associate director/regulatory group leader at Kendle International, and before that she was the principal statistician and senior manager of regulatory affairs at Wyeth.
Share this content:
Scroll down to see the next article